KYOWA KIRIN CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public, Subsidiary
- Established
- 1949-07-01
- Employees
- 5.9K
- Market Cap
- -
- Website
- http://www.kyowa-kirin.co.jp
A Clinical Pharmacology Study of Bardoxolone Methyl in Healthy Adults
- First Posted Date
- 2019-07-18
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT04023903
- Locations
- 🇯🇵
Medical Corporation Heishinkai OPHAC Hospital, Osaka, Japan
A Study of RTA 402 in Obese Adults
- First Posted Date
- 2019-07-12
- Last Posted Date
- 2020-06-23
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 22
- Registration Number
- NCT04018339
- Locations
- 🇯🇵
Applied Bio-Pharmatech Kurume Clinical Pharmacology Clinic, Kurume, Fukuoka, Japan
KRN125 for Mobilization of Hematopoietic Stem Cells
Phase 2
Completed
- Conditions
- Peripheral Blood Stem Cell Transplantation
- Interventions
- First Posted Date
- 2019-06-21
- Last Posted Date
- 2021-01-22
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 35
- Registration Number
- NCT03993639
- Locations
- 🇯🇵
Hokkaido University Hospital, Sapporo, Hokkaido, Japan
Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma
Phase 1
Active, not recruiting
- Conditions
- Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma
- Interventions
- First Posted Date
- 2019-06-13
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 14
- Registration Number
- NCT03985189
- Locations
- 🇯🇵
The Cancer Institute Hospital of JFCR, Koto-ku, Tokyo, Japan
🇯🇵Aomori Prefectural Central Hospital, Aomori, Japan
🇯🇵Kyushu University Hospital, Fukuoka, Japan
A Drug Interaction Study of KW-6356 With Midazolam, Caffeine, or Rosuvastatin
Phase 1
Completed
- Conditions
- Parkinson's Disease
- Interventions
- First Posted Date
- 2019-06-03
- Last Posted Date
- 2019-11-29
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT03970798
- Locations
- 🇯🇵
Fukuoka Mirai Hospital Clinical Research Center, Fukuoka, Japan
A Phase 3 Study of KHK4827 in Patients With Systemic Sclerosis
Phase 3
Active, not recruiting
- Conditions
- Moderate to Severe Systemic Sclerosis
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-05-21
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT03957681
- Locations
- 🇯🇵
The University of Tokyo Hospital, Tokyo, Bunkyo-ku, Japan
🇯🇵Chukyo Hospital, Nagoya, Aichi, Japan
🇯🇵Osaka University Hospital, Suita, Osaka, Japan
Study of AMG531(Romiplostim) in Patients With Aplastic Anemia
- First Posted Date
- 2019-05-21
- Last Posted Date
- 2022-05-26
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 17
- Registration Number
- NCT03957694
- Locations
- 🇯🇵
Matsuyama Red Cross Hospital, Ehime, Japan
Dose-finding Study of KHK7791 in Hyperphosphatemia Patients
- First Posted Date
- 2019-03-06
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 207
- Registration Number
- NCT03864458
- Locations
- 🇯🇵
Study Site 1, Nagoya, Japan
Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients
- First Posted Date
- 2019-03-06
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 47
- Registration Number
- NCT03864445
- Locations
- 🇯🇵
Study Site 1, Chiba, Japan
Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic Dermatitis
Phase 1
Terminated
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: Placebo IV/SDrug: Placebo IV/MDrug: KHK4323 IV/SDrug: Placebo SC/SDrug: KHK4323 IV/MDrug: KHK4323 SC/S
- First Posted Date
- 2019-02-19
- Last Posted Date
- 2020-01-28
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 5
- Registration Number
- NCT03846466
- Locations
- 🇯🇵
Osaka Pharmacology Clinical research Hospital, Osaka, Japan
© Copyright 2025. All Rights Reserved by MedPath